Protein Kinase D-dependent Phosphorylation and Nuclear Export of Histone Deacetylase 5 Mediates Vascular Endothelial Growth Factor-induced Gene Expression and Angiogenesis
Overview
Authors
Affiliations
Vascular endothelial growth factor (VEGF) is essential for normal and pathological angiogenesis. However, the signaling pathways linked to gene regulation in VEGF-induced angiogenesis are not fully understood. Here we demonstrate a critical role of protein kinase D (PKD) and histone deacetylase 5 (HDAC5) in VEGF-induced gene expression and angiogenesis. We found that VEGF stimulated HDAC5 phosphorylation and nuclear export in endothelial cells through a VEGF receptor 2-phospholipase Cgamma-protein kinase C-PKD-dependent pathway. We further showed that the PKD-HDAC5 pathway mediated myocyte enhancer factor-2 transcriptional activation and a specific subset of gene expression in response to VEGF, including NR4A1, an orphan nuclear receptor involved in angiogenesis. Specifically, inhibition of PKD by overexpression of the PKD kinase-negative mutant prevents VEGF-induced HDAC5 phosphorylation and nuclear export as well as NR4A1 induction. Moreover, a mutant of HDAC5 specifically deficient in PKD-dependent phosphorylation inhibited VEGF-mediated NR4A1 expression, endothelial cell migration, and in vitro angiogenesis. These findings suggest that the PKD-HDAC5 pathway plays an important role in VEGF regulation of gene transcription and angiogenesis.
Targeting intracellular proteins with cell type-specific functions for cancer immunotherapy.
Carelock M, Master R, Kim M, Jin Z, Wang L, Maharjan C Life Med. 2025; 2(3):lnad019.
PMID: 39872303 PMC: 11749652. DOI: 10.1093/lifemedi/lnad019.
Li J, Yao Y, Zhou J, Yang Z, Qiu C, Lu Y Nat Commun. 2024; 15(1):9105.
PMID: 39438477 PMC: 11496666. DOI: 10.1038/s41467-024-53531-8.
A Novel Gene Fusion YLPM1::PRKD1 Identified in a Cribriform Subtype of Polymorphous Adenocarcinoma.
Miyakawa-Liu M, Ozawa M, Chen M, Rahman M Head Neck Pathol. 2024; 18(1):43.
PMID: 38735907 PMC: 11089030. DOI: 10.1007/s12105-024-01648-z.
PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy.
Wang L, Xiao Y, Luo Y, Master R, Mo J, Kim M J Exp Med. 2024; 221(3).
PMID: 38334978 PMC: 10857906. DOI: 10.1084/jem.20231519.
Dysregulation of histone deacetylases in ocular diseases.
Jun J, Kim J, Palomera L, Jo D Arch Pharm Res. 2023; 47(1):20-39.
PMID: 38151648 DOI: 10.1007/s12272-023-01482-x.